Can you provide the upcoming earnings date for XENETIC BIOSCIENCES INC?
XENETIC BIOSCIENCES INC (XBIO) will report earnings on 2026-05-11.
XENETIC BIOSCIENCES INC (XBIO) Forecast, Price Target & Analyst Ratings
NASDAQ:XBIO • US9840156023
Current stock price
3.08 USD
+0.03 (+0.98%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for XENETIC BIOSCIENCES INC (XBIO).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $3.08 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
XBIO was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about XBIO.
In the previous month the buy percentage consensus was at a similar level.
XBIO was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-04-09 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-03-20 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-12-05 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-22 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-08-20 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-05-16 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-04-11 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-05-02 | HC Wainwright & Co. | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 11, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2026 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.54M 48.54% | 2.5M -1.56% | 2.976M 19.04% | 3.06M 2.81% | 2.55M -16.67% | |
| EBITDA YoY % growth | -4.516M 34.89% | N/A -40.04% | N/A 45.16% | -6.12M -76.47% | -9.69M -58.33% | |
| EBIT YoY % growth | -4.516M 32.80% | -3.5M 22.49% | -2.835M 19.01% | -6.12M -115.90% | -9.69M -58.33% | |
| Operating Margin | -177.78% | -139.98% | -95.24% | -200.00% | -380.00% | |
| EPS YoY % growth | -2.75 41.49% | -2.57 6.55% | N/A 19.04% | -3.39 -62.75% | -0.35 89.76% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A